Bristol-Myers Squibb buy Daiwa Capital Markets
Start price
28.06.23
/
50%
€59.00
Target price
28.06.24
€64.04
Performance (%)
-33.56%
End price
29.06.24
€39.20
Summary
This prediction ended on 29.06.24 with a price of €39.20. The BUY prediction by Daiwa_Capital_Market for Bristol-Myers Squibb performed very badly with a performance of -33.56%. Dividends of €2.16 are taken into consideration when calculating the performance. Daiwa_Capital_Market has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bristol-Myers Squibb | -1.591% | -1.591% | -7.776% |
| iShares Core DAX® | -6.016% | -4.595% | 1.284% |
| iShares Nasdaq 100 | 0.511% | 0.164% | 14.401% |
| iShares Nikkei 225® | -7.156% | -2.215% | 27.886% |
| iShares S&P 500 | -0.257% | -0.841% | 10.254% |
Comments by Daiwa_Capital_Market for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol-Myers Squibb (NYSE: BMY) is now covered by analysts at Daiwa Capital Markets. They set an "outperform" rating and a $70.00 price target on the stock.
Ratings data for BMY provided by MarketBeat
In the thread Trading Bristol-Myers Squibb
Die von Daiwa_Capital_Market gewählte maximale Laufzeit wurde überschritten